Literature DB >> 12222841

Pleomorphic primitive neuroectodermal tumor with glial and neuronal differentiation: clinical, pathological, cultural, and chromosomal analysis of a case.

Yuji Uematsu1, Rie Takehara, Mina Shimizu, Yoshiyuki Tanaka, Toru Itakura, Norihiko Komai.   

Abstract

This paper examines a case of pleomorphic primitive neuroectodermal tumor (PNET) with glial and neuronal differentiation in a 7-year-old girl who was clinicopathologically reported with immunohistochemical and chromosomal analysis. Clinically, a highly aggressive behavior leading to early recurrence with cerebrospinal fluid seedings was characteristic despite total removal and chemoradiation therapy. Pathologically, severe pleomorphism was noted and large ganglioid cells were predominant. Immunohistochemically, the expression of low-molecular neurofilament was recognized in the surgical specimens and increased in the recurrence. Coexpression of vimentin and neurofilament/GFAP was recognized in the culture. Chromosomal analysis showed near-diploidy, but different karyotype from that PNETs previously reported. These findings suggested that PNETs with pleomorphism and differentiation into both glial and neuronal lineages may show aggressiveness and require more aggressive therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12222841     DOI: 10.1023/a:1016321030590

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.

Authors:  D A Reardon; J J Jenkins; J E Sublett; P C Burger; L K Kun
Journal:  Pediatr Neurosurg       Date:  2000-04       Impact factor: 1.162

2.  Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms.

Authors:  D C Miller; M Koslow; G N Budzilovich; D E Burstein
Journal:  Hum Pathol       Date:  1990-03       Impact factor: 3.466

Review 3.  Primitive neuroectodermal tumors of the central nervous system.

Authors:  L B Rorke; J Q Trojanowski; V M Lee; R A Zimmerman; L N Sutton; J A Biegel; J W Goldwein; R J Packer
Journal:  Brain Pathol       Date:  1997-04       Impact factor: 6.508

Review 4.  Cerebral primitive neuroectodermal tumors in childhood.

Authors:  T Tomita; D G McLone; M Yasue
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

5.  Protein gene product (PGP) 9.5 as a reliable marker in primitive neuroectodermal tumours--an immunohistochemical study of 21 childhood cases.

Authors:  M D Harris; I E Moore; P V Steart; R O Weller
Journal:  Histopathology       Date:  1990-03       Impact factor: 5.087

6.  Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.

Authors:  V E Gould; D S Jansson; W M Molenaar; L B Rorke; J Q Trojanowski; V M Lee; R J Packer; W W Franke
Journal:  Lab Invest       Date:  1990-04       Impact factor: 5.662

7.  Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

Authors:  J Bayani; M Zielenska; P Marrano; Y Kwan Ng; M D Taylor; V Jay; J T Rutka; J A Squire
Journal:  J Neurosurg       Date:  2000-09       Impact factor: 5.115

8.  Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.

Authors:  W M Molenaar; D S Jansson; V E Gould; L B Rorke; W W Franke; V M Lee; R J Packer; J Q Trojanowski
Journal:  Lab Invest       Date:  1989-12       Impact factor: 5.662

9.  A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.

Authors:  A J Caputy; D C McCullough; H J Manz; K Patterson; M K Hammock
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

10.  An immunohistochemical study of human central and peripheral nervous system tumors, using monoclonal antibodies against neurofilaments and glial filaments.

Authors:  J Q Trojanowski; V M Lee; W W Schlaepfer
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

View more
  1 in total

1.  Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Authors:  Suzanne Miller; Hazel A Rogers; Paul Lyon; Vikki Rand; Martyna Adamowicz-Brice; Steven C Clifford; James T Hayden; Sara Dyer; Stefan Pfister; Andrey Korshunov; Marie-Anne Brundler; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.